Skip to main content

In new Regeneron deal for COVID drug, White House imposes price limits for first time

By STAT News  
   September 14, 2023

A groundbreaking clause in a new deal between HHS and Regeneron marks the first time the Biden administration has directly used its leverage to challenge drugmakers' list prices.

Full story

Get the latest on healthcare leadership in your inbox.